吉西他滨
医学
肿瘤科
内科学
临床终点
人口
奥沙利铂
化疗
随机对照试验
癌症
结直肠癌
环境卫生
作者
Zev A. Wainberg,Davide Melisi,Teresa Macarulla,Roberto Pazo-Cid,Sreenivasa R Chandana,Christelle de la Fouchardière,Andrew Dean,Igor Kišš,Woo Jin Lee,Thorsten Oliver Goetze,Eric Van Cutsem,Andrew Scott Paulson,Tanios Bekaii‐Saab,Shubham Pant,Richard Hubner,Zhimin Xiao,Huanyu Chen,Fawzi Benzaghou,Eileen M. O’Reilly
出处
期刊：The Lancet
[Elsevier BV]
日期：2023-09-11
卷期号：402 (10409): 1272-1281
被引量：260
标识
DOI：10.1016/s0140-6736(23)01366-1
摘要
Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies, with few treatment options. NAPOLI 3 aimed to compare the efficacy and safety of NALIRIFOX versus nab-paclitaxel and gemcitabine as first-line therapy for metastatic pancreatic ductal adenocarcinoma (mPDAC).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
馆长
LMW
null
遇上就这样吧
GingerF
贰鸟
彩虹儿
小愿张
鸣笛
从容芮
pcr163
vizi
Virtual
Maestro_S
Shuo
Dr_Zhan
leaolf
54188
lzxbarry
等待八宝粥
皖公网安备34019202002308
